[%TAGS (074db819ec% %074db819ec) %]
(074db819ec% IF user.email && action == 'arc' %074db819ec)
(074db819ec% END %074db819ec)
- From: Bernard Lang <Bernard.Lang@inria.fr>
- To: Hartmut Pilch <phm@a2e.de>, Seth Johnson <seth.johnson@RealMeasures.dyndns.org>
- Cc: C-FIT_Community@RealMeasures.dyndns.org, C-FIT_Release_Community@RealMeasures.dyndns.org, fairuse-discuss@nyfairuse.org, DMCA_Discuss@lists.microshaft.org, rms@gnu.org, patents@aful.org, fos-forum@topica.com
- Subject: Re: [Patents] Article Defending Bayh-Dole
- Date: Fri, 25 Apr 2003 08:55:21 +0200
On Thu, Apr 24, 2003 at 07:08:01PM +0200, Hartmut Pilch wrote:
> This seems to be the core piece of the article which needs to be
> scrutinised. I'd suspect that it is a historic myth, but where's the
> evidence?
>
> > For 30 years after World War II, the United States had precisely the
> > policy of nonexclusive licensing of federally funded inventions that
> > Shulman advocates. The government owned the patents and would license
> > them only on a nonexclusive basis. Under this system, no drug that the
> > government owned rights to was ever developed and became available to
> > the public.
>
> This insinuates that drugs will only be commercialised if someone owns
> exclusive rights. I.e. once patents expire nobody will produce the drug
> anymore because there is no sufficient margin. Thus generic drugs don't
> exist or are in short supply. Is that true?
If I understand correctly, a new drug has to be tested before being
sold, and the testing is very expensive. I think that generics may no
longer need to be tested (since they were before they became generics).
So that would make a difference.
But of course this difference is based on investment cost (after the
invention is produced) and on distribution costs. Hence it does not
apply to software.
I do not know whether patents are good or bad in biotechs. What I
do know is that relevant parameters vary with every area, and may even
change over time. So the one size fits all policies of dumb lawyers /
politicians / ideologists / netbots is just as much nonsense.
Bernard
--
Non aux Brevets Logiciels - No to Software Patents
SIGNEZ http://petition.eurolinux.org/ SIGN
Bernard.Lang@inria.fr ,_ /\o \o/ Tel +33 1 3963 5644
http://pauillac.inria.fr/~lang/ ^^^^^^^^^^^^^^^^^ Fax +33 1 3963 5469
INRIA / B.P. 105 / 78153 Le Chesnay CEDEX / France
Je n'exprime que mon opinion - I express only my opinion
CAGED BEHIND WINDOWS or FREE WITH LINUX
(074db819ec%|loc%074db819ec)Archive powered by(074db819ec%END%074db819ec) MhonArc 2.6.16.
(074db819ec%TAGS [% %]%074db819ec)